Related references
Note: Only part of the references are listed.Ecotopic viral integration site 1 (EVI1) regulates multiple cellular processes important for cancer and is a synergistic partner for FOS protein in invasive tumors
Emilie A. Bard-Chapeau et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Ikaros, CK2 kinase, and the road to leukemia
Sinisa Dovat et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2011)
Addiction to protein kinase CK2: A common denominator of diverse cancer cells?
Maria Ruzzene et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2010)
A Tissue-Specific Atlas of Mouse Protein Phosphorylation and Expression
Edward L. Huttlin et al.
CELL (2010)
Acetylation of Lysine 564 Adjacent to the C-terminal Binding Protein-binding Motif in EVI1 Is Crucial for Transcriptional Activation of GATA2
Akiko Shimahara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci
Jin-Xin Bei et al.
NATURE GENETICS (2010)
Gene therapy activates EVI1, destabilizes chromosomes
Cynthia E. Dunbar et al.
NATURE MEDICINE (2010)
Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease
Stefan Stein et al.
NATURE MEDICINE (2010)
Potential predictive markers of chemotherapy resistance in stage III ovarian serous carcinomas
Lovisa Osterberg et al.
BMC CANCER (2009)
CDC25B Mediates Rapamycin-induced Oncogenic Responses in Cancer Cells
Run-qiang Chen et al.
CANCER RESEARCH (2009)
EVI1 Impairs Myelopoiesis by Deregulation of PU.1 Function
Leopoldo Laricchia-Robbio et al.
CANCER RESEARCH (2009)
Pathogenetic significance of ecotropic viral integration site-1 in hematological malignancies
Susumu Goyama et al.
CANCER SCIENCE (2009)
A SILAC-based DNA protein interaction screen that identifies candidate binding proteins to functional DNA elements
Gerhard Mittler et al.
GENOME RESEARCH (2009)
Ikaros Stability and Pericentromeric Localization Are Regulated by Protein Phosphatase 1
Marcela Popescu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
RVB1/RVB2: Running Rings around Molecular Biology
Sudhakar Jha et al.
MOLECULAR CELL (2009)
Mislocalized Activation of Oncogenic RTKs Switches Downstream Signaling Outcomes
Chunaram Choudhary et al.
MOLECULAR CELL (2009)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
A Transposon-Based Genetic Screen in Mice Identifies Genes Altered in Colorectal Cancer
Timothy K. Starr et al.
SCIENCE (2009)
High EVI1 levels predict adverse outcome in acute myeloid leukemia:: prevalence of EVI1 overexpression. and chromosome 3q26 abnormalities underestimated
Sanne Lugthart et al.
BLOOD (2008)
Pontin and Reptin, two related ATPases with multiple roles in cancer
Otmar Huber et al.
CANCER RESEARCH (2008)
Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome
Richard W. Tothill et al.
CLINICAL CANCER RESEARCH (2008)
Recruitment of Ikaros to pericentromeric heterochromatin is regulated by phosphorylation
Zafer Gurel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Protein kinase CK2 as a druggable target
Stefania Sarno et al.
MOLECULAR BIOSYSTEMS (2008)
The MDS1-EVI1 gene complex as a retrovirus integration site: Impact on behavior of hematopoietic cells and implications for gene therapy
Jean-Yves Metais et al.
MOLECULAR THERAPY (2008)
The oncogene and developmental regulator EVI1: Expression, biochemical properties, and biological functions
Rotraud Wieser
GENE (2007)
Affinity-purification mass spectrometry (AP-MS) of serine/threonine phosphatases
Ginny I. Chen et al.
METHODS (2007)
Repression of RUNX1 activity by EVI1: A new role of EVI1 in leukemogenesis
Vitalyi Senyuk et al.
CANCER RESEARCH (2007)
ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage
Shuhei Matsuoka et al.
SCIENCE (2007)
Amplification of MDS1/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer
Meera Nanjundan et al.
CANCER RESEARCH (2007)
Comparative genomic hybridization array analysis and real time PCR reveals genomic alterations in squamous cell carcinomas of the lung
Yong-Woo Choi et al.
LUNG CANCER (2007)
Point mutations in two EVI1 Zn fingers abolish EVI1-GATA1 interaction and allow erythroid differentiation of murine bone marrow cells
Leopoldo Laricchia-Robbio et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
EVI1 and hematopoietic disorders: History and perspectives
G Nucifora et al.
GENE (2006)
In-gel digestion for mass spectrometric characterization of proteins and proteomes
Andrej Shevchenko et al.
NATURE PROTOCOLS (2006)
Prognostically useful gene-expression profiles in acute myeloid leukemia
PJM Valk et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
A statistical model for identifying proteins by tandem mass spectrometry
AI Nesvizhskii et al.
ANALYTICAL CHEMISTRY (2003)
Proteomic analysis of post-translational modifications
M Mann et al.
NATURE BIOTECHNOLOGY (2003)
Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics
SE Ong et al.
MOLECULAR & CELLULAR PROTEOMICS (2002)
Interaction of EVI1 with cAMP-responsive element-binding protein-binding protein (CBP) and p300/CBP-associated factor (P/CAF) results in reversible acetylation of EVI1 and in co-localization in nuclear speckles
S Chakraborty et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding
JE Garrus et al.
CELL (2001)
Oncogenic mechanisms of Evi-1 protein
H Hirai et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2001)
The corepressor CtBP interacts with Evi-1 to repress transforming growth factor β signaling
K Izutsu et al.
BLOOD (2001)
The Evi-1 oncoprotein inhibits c-Jun N-terminal kinase and prevents stress-induced cell death
M Kurokawa et al.
EMBO JOURNAL (2000)
Share Paper
